Volume 11, Number 7—July 2005
Dispatch
New Lymphogranuloma Venereum Chlamydia trachomatis Variant, Amsterdam
Table
Characteristics of men who have sex with men in retrospective study at sexually transmitted disease outpatient clinic in Amsterdam, the Netherlands*
| Clinical data | MMA+ |
MMA– |
||||
|---|---|---|---|---|---|---|
| (2002 and 2003) |
(2003) |
|||||
| C. trachomatis |
C. trachomatis |
|||||
| L2b | Non-LGV | Total | L2b | Non-LGV | Total | |
| No. patients | 32 | 12† | 44 | 13 | 17‡ | 30 |
| Anal discharge | 11 | 3 | 14 | 4 | 2 | 6 |
| Genital ulcers | 3 (L2b) | 1 (Treponema pallidum) | 4 | 0 | 1 (HSV-2) | 1 |
| Lymphadenopathy | 4 | 0 | 4 | 2 | 2 | 4 |
| Mean no. infections with sexually transmitted diseases | 8.3 | 5.8 | 7.8 | 7 | 4.6 | 5.8 |
| Known HIV+ | 24 | 6 | 30 | 7 | 7 | 14 |
| >10 leukocytes by Gram stain | 26 | 3 | 39 | 3 | 6 | 9 |
| C. trachomatis lgG ≥200 | 22 | 2 | 24 | 8 | 6 | 14 |
| C. trachomatis lgG <200 | 8§ | 10 | 18 | 4¶ | 11 | 15 |
*MMA, mucous membrane abnormalities; C. trachomatis, Chlamydia trachomatis; LGV, lymphogranuloma venereum; Ig, immunoglobulin.
†2 serum samples were not available for testing.
‡1 serum sample was not available for testing.
§Serogroup B, n = 5; intermediate serogroup, n = 5; serogroup C, n = 2.
¶Serogroup B, n = 10; intermediate serogroup, n = 1; serogroup C, n = 6.


